In a feat of computational biology, researchers design novel proteins capable of neutralizing a key influenza protein
The Scientist
Most Recent
A new vaccine that uses a persistent virus vector controlled SIV in 50 percent of tested monkeys
Does mitochondrial dysfunction lie at the heart of common, complex diseases like cancer and autism?
Clostridium difficile is evolving more robust toxicity, repeatedly attacking its victims, and driving the search for alternative therapies to fight the infection.
By forging new relationships and finding novel uses for existing technologies, this year’s top companies are employing creative ways to advance their science.
A promising gene therapy trial, derailed by cancerous side effects in a young patient, is set to reboot with the help of next generation gene-transfer vectors.
Are miRNAs useful for tracking and treating cardiovascular disease?
Understanding oncogenesis at the molecular level offers the prospect of tailoring treatments much more precisely for patients with advanced cases of this deadliest of skin cancers.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
